#HAE #HereditaryAngioedema #Navenibart #RareDisease #PharmaNews #MedicalInnovation #AstriaTherapeutics #KakenPharmaceutical #ClinicalTrials #BioNews #AngioedemaNews
0
0
0
0
#HAE #HereditaryAngioedema #Navenibart #RareDisease #PharmaNews #MedicalInnovation #AstriaTherapeutics #KakenPharmaceutical #ClinicalTrials #BioNews #AngioedemaNews
(NASDAQ: #ATXS)
#AstriaTherapeutics partners with Kaken Pharma to bring navenibart, a potential HAE treatment, to Japan with a $16M deal and milestone payments ahead.
prismmarketview.com/astria-thera...